The clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with an investigational intervention that employs viruses to destroy tumors, a Ludwig Cancer Research study has suggested. Published today in the journal iScience Translational Medicine/i, the study evaluated a combination therapy in which the Newcastle disease virus (NDV), a bird virus not ordinarily ...
Read More
You have just read an article categorized health
titled Research Sheds Light on Going Viral to Target Tumors.
Written by:
editor -
Friday, March 7, 2014
There are currently no comments for "Research Sheds Light on Going Viral to Target Tumors"
Post a Comment